BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29353074)

  • 1. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
    Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
    J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.
    Xi LF; Koutsky LA; Castle PE; Wheeler CM; Galloway DA; Mao C; Ho J; Kiviat NB
    J Natl Cancer Inst; 2009 Feb; 101(3):153-61. PubMed ID: 19176451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
    J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
    Xi LF; Koutsky LA; Hildesheim A; Galloway DA; Wheeler CM; Winer RL; Ho J; Kiviat NB
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):4-10. PubMed ID: 17220325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species.
    Xi LF; Edelstein ZR; Meyers C; Ho J; Cherne SL; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2507-12. PubMed ID: 19690188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer.
    Hesselink AT; Berkhof J; Heideman DA; Bulkmans NW; van Tellingen JE; Meijer CJ; Snijders PJ
    Int J Cancer; 2009 Jan; 124(2):381-6. PubMed ID: 19003961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
    Keegan H; Mc Inerney J; Pilkington L; Grønn P; Silva I; Karlsen F; Bolger N; Logan C; Furuberg L; O'Leary J; Martin C
    J Virol Methods; 2009 Jan; 155(1):61-6. PubMed ID: 18955086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopy.
    Carcopino X; Henry M; Mancini J; Giusiano S; Boubli L; Olive D; Tamalet C
    J Med Virol; 2012 Feb; 84(2):306-13. PubMed ID: 22170552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
    Gravitt PE; Kovacic MB; Herrero R; Schiffman M; Bratti C; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Rodriguez AC; Burk RD
    Int J Cancer; 2007 Dec; 121(12):2787-93. PubMed ID: 17722112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysis.
    van der Marel J; van Baars R; Quint WG; Berkhof J; del Pino M; Torné A; Ordi J; Wentzensen N; Schiffman M; van de Sandt MM; Lindeman J; Jenkins D; Helmerhorst TJ; Verheijen RH; ter Harmsel B; Alonso I
    BJOG; 2014 Aug; 121(9):1117-26. PubMed ID: 24494663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two years outcome of women infected with high risk HPV having normal colposcopy following low-grade or equivocal cytological abnormalities: are HPV16 and 18 viral load clinically useful predictive markers?
    Carcopino X; Henry M; Mancini J; Giusiano S; Boubli L; Olive D; Tamalet C
    J Med Virol; 2012 Jun; 84(6):964-72. PubMed ID: 22499020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
    Kreimer AR; Schiffman M; Herrero R; Hildesheim A; González P; Burk RD; Porras C; Sherman ME; Demuth F; Cheung L; Bratti C; Cecilia Rodríguez A
    Int J Cancer; 2012 Jul; 131(1):211-8. PubMed ID: 21823117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays.
    Roberts CC; Tadesse AS; Sands J; Halvorsen T; Schofield TL; Dalen A; Skjeldestad FE; Jansen KU
    J Clin Virol; 2006 Aug; 36(4):277-82. PubMed ID: 16765639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.
    Wang SM; Colombara D; Shi JF; Zhao FH; Li J; Chen F; Chen W; Li SM; Zhang X; Pan QJ; Belinson JL; Smith JS; Qiao YL
    Int J Gynecol Cancer; 2013 May; 23(4):716-23. PubMed ID: 23455757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.
    Carcopino X; Henry M; Benmoura D; Fallabregues AS; Richet H; Boubli L; Tamalet C
    J Med Virol; 2006 Aug; 78(8):1131-40. PubMed ID: 16789021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.